The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma-Reference-Cited by-同舟云学术

The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma

Published:2017-10-10 Issue:56 Volume:8 Page:96103-96116
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Li Xiao¹²,Tang Jingyuan¹³,Huang Wen⁴,Wang Feng¹,Li Pu¹,Qin Chao¹,Qin Zhiqiang¹,Zou Qing²,Wei Jifu⁴,Hua Lixin¹,Yang Haiwei¹,Wang Zengjun¹

Affiliation:

1. State Key Laboratory of Reproductive Medicine, Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

2. Department of Urology, Affiliated Cancer Hospital of Jiangsu Province of Nanjing Medical University, Nanjing 210009, China

3. Department of Urology, Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of TCM, Nanjing 210029,China

4. Research Division of Clinical Pharmacology, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refining the role of N6-methyladenosine in cancer;Current Opinion in Genetics & Development;2024-10

2. N6-methyladenosine triggers renal fibrosis via enhancing translation and stability of ZEB2 mRNA;Journal of Biological Chemistry;2024-09

3. Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target;Journal of Medicinal Chemistry;2024-08-16

4. Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo;European Journal of Medical Research;2024-08-05

5. The potential of RNA methylation in the treatment of cardiovascular diseases;iScience;2024-08